MicroRNA-152 targets ADAM17 to suppress NSCLC progression

被引:64
作者
Su, Yunshu [1 ]
Wang, Yuchang [1 ]
Zhou, Hongmin [1 ]
Lei, Lei [1 ]
Xu, Lijun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiothorac Surg, Wuhan 430030, Hubei, Peoples R China
来源
FEBS LETTERS | 2014年 / 588卷 / 10期
关键词
Non-small cell lung cancer; miR-152; ADAM metallopeptidase domain 17; Proliferation; Migration; Invasion; MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; GROWTH; PROMOTES; MOTILITY; INVASION; MIR-152; FAMILY;
D O I
10.1016/j.febslet.2014.04.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are a class of small non-coding RNAs that have been suggested to play an essential role in tumorigenesis. In this study, we show that miR-152 is significantly downregulated in non-small cell lung cancer (NSCLC) tissues and cell lines. Restoration of miR-152 significantly reduces proliferation, colony formation, migration and invasion of NSCLC cells. In addition, ADAM metallopeptidase domain 17 (ADAM17) is identified as a target of miR-152 in NSCLC cells, and miR-152-induced suppression of cell proliferation, colony formation, migration and invasion is partially mediated by silencing of ADAM17 expression. Furthermore, ADAM17 inversely correlates with miR-152 in NSCLC tissues. Collectively, our findings indicate that miR-152 acts as tumor suppressor in NSCLC partially via targeting ADAM17. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1983 / 1988
页数:6
相关论文
共 23 条
  • [1] Noncoding RNAs and Atherosclerosis
    Aryal, Binod
    Rotllan, Noemi
    Fernandez-Hernando, Carlos
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (05)
  • [2] Azizi M., 2014, CANC BIOL THER, V15
  • [3] Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells
    Blanchot-Jossic, F
    Jarry, A
    Masson, D
    Bach-Ngohou, K
    Paineau, J
    Denis, MG
    Laboisse, CL
    Mosnier, JF
    [J]. JOURNAL OF PATHOLOGY, 2005, 207 (02) : 156 - 163
  • [4] ADAM17 mRNA expression and pathological features of hepatocellular carcinoma
    Ding, Xiang
    Yang, Lian-Yue
    Huang, Gen-Wen
    Wang, Wei
    Lu, Wei-Qun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (18) : 2735 - 2739
  • [5] Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting DNA Methyltransferase 1
    Huang, Jinfeng
    Wang, Yue
    Guo, Yingjun
    Sun, Shuhan
    [J]. HEPATOLOGY, 2010, 52 (01) : 60 - 70
  • [6] Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells
    Ke, Yang
    Zhao, Weiyong
    Xiong, Jie
    Cao, Rubo
    [J]. FEBS LETTERS, 2013, 587 (18): : 3153 - 3157
  • [7] Specificity Protein 1 ( Sp1) Maintains Basal Epithelial Expression of the miR-200 Family
    Kolesnikoff, Natasha
    Attema, Joanne L.
    Roslan, Suraya
    Bert, Andrew G.
    Schwarz, Quenten P.
    Gregory, Philip A.
    Goodall, Gregory J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (16) : 11194 - 11205
  • [8] miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN
    Lei, Lin
    Huang, Yaping
    Gong, Wenrong
    [J]. ONCOLOGY REPORTS, 2013, 30 (06) : 2897 - 2902
  • [9] ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer
    Lv, Xiaohong
    Li, Yang
    Qian, Ming
    Ma, Chengyuan
    Jing, Hongyu
    Wen, Zhongmei
    Qian, Donghua
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1935 - 1940
  • [10] Comparison of the Surgical Outcomes of Thoracoscopic Lobectomy, Segmentectomy, and Wedge Resection for Clinical Stage I Non-Small Cell Lung Cancer
    Nakamura, H.
    Taniguchi, Y.
    Miwa, K.
    Adachi, Y.
    Fujioka, S.
    Haruki, T.
    Takagi, Y.
    Yurugi, Y.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (03) : 137 - 141